Turkish oncologists and thoracic surgeons collaborate through multidisciplinary tumor boards to coordinate lung cancer treatment. Specialists like Dr. Mustafa Solak and Dr. Altan Kir review cases together to determine the best sequence for chemotherapy and surgery. This team approach targets accurate staging and personalized care plans.
- Tumor board reviews: Teams of oncologists, surgeons, and radiologists meet weekly to review complex lung cases.
- Treatment sequencing: Experts decide if chemotherapy should happen before or after surgery to shrink tumors.
- Specialized planning: Surgeons assess resectability while oncologists evaluate systemic health and advanced immunotherapy options.
- Integrated diagnostics: Teams use EBUS and PET/CT results together to ensure precise surgical margins.
Bookimed Expert Insight: Data shows that top Turkish specialists often hold international credentials that bridge oncology and surgery. For example, Dr. Alper Toker serves as President of the European Society of Thoracic Surgeons, while Dr. Mustafa Solak trained at MD Anderson Cancer Center. This international exposure helps these doctors lead multidisciplinary teams that align with global standards for complex lung cancer cases.
Patient Consensus: Patients note that surgeons and oncologists work as a single team from the first day. They appreciate that cases are reviewed collectively, which often leads to faster surgery dates than in Europe. Many feel more confident knowing their entire treatment path was decided by a group of specialists.
